Trial ID or NCT#

NCT01827046

Status

RECRUITING

Purpose

A phase III, randomized, case-controlled, open-label, 500-subject clinical trial of minimally invasive surgery plus rt-PA in the treatment of intracerebral hemorrhage (ICH).

Official Title

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Chitra Venkatasubramanian, MBBS, MD, MSc.
Neurocritical care specialist, Stroke and vascular neurologist
Clinical Professor, Neurology & Neurological Sciences
Gordon Li, MD
Neurosurgeon
Associate Professor of Neurosurgery and, by courtesy, of Neurology and of Otolaryngology-Head and Neck Surgery at the Stanford University Medical Center
Ciara Harraher, MD
Neurosurgeon, Spine neurosurgeon, Trauma neurosurgeon
Clinical Associate Professor, Neurosurgery

Contact us to find out if this trial is right for you.

CONTACT

Madelleine Garcia
(650) 723-4448